← Caregiver glossary · Medical concepts

Caregiver glossary

Fall-risk medication

Also: high-risk medication for older adults

Medications associated with increased fall risk in older adults — particularly benzodiazepines (lorazepam, alprazolam, etc.), sleep medications (zolpidem), opioids, anticholinergics (diphenhydramine, oxybutynin), and some antidepressants. The Beers Criteria, published by the American Geriatrics Society, is the standard reference.

What it means in practice

Falls are the leading cause of injury death in adults 65+. About 1 in 4 older adults falls each year; 1 in 5 falls causes serious injury. Medications are a substantial, modifiable contributor — usually estimated to be implicated in 20-40% of falls in older adults.

The Beers Criteria (American Geriatrics Society, updated regularly; current 2023 edition) is the standard reference for "potentially inappropriate medications" in adults 65+. It lists drugs with elevated risk-benefit ratios in this population, organized by drug class. Always-avoid categories include first-generation antihistamines (Benadryl, hydroxyzine), barbiturates, meprobamate, and certain antipsychotics outside specific indications.

Highest-risk medication classes for falls specifically: • **Benzodiazepines** (lorazepam/Ativan, alprazolam/Xanax, clonazepam/Klonopin, diazepam/Valium) — sedation + impaired balance + impaired judgment • **Z-drugs (sleep medications)** (zolpidem/Ambien, eszopiclone/Lunesta, zaleplon/Sonata) — middle-of-night falls are common • **Opioids** (oxycodone, hydrocodone, tramadol, morphine, fentanyl) — sedation + dizziness + constipation that drives bathroom trips • **Anticholinergics**: first-generation antihistamines (Benadryl), tricyclic antidepressants (amitriptyline, nortriptyline), oxybutynin (for bladder), some antipsychotics — cognitive impairment + blurred vision + orthostatic hypotension • **Some antidepressants**: TCAs (above) more than SSRIs; even SSRIs increase fall risk modestly • **Antipsychotics** (haloperidol, risperidone, quetiapine) — often prescribed off-label for dementia behavioral symptoms; FDA black-box warning for increased mortality in dementia + significant fall risk • **Cardiovascular medications causing orthostatic hypotension**: alpha-blockers (terazosin, doxazosin), some diuretics, vasodilators • **Anticonvulsants**: gabapentin, pregabalin — increasingly prescribed for off-label uses; cause dizziness, sedation, balance problems

Deprescribing strategy: • Annual medication review with the PCP or pharmacist, ideally with the Beers Criteria in hand • Identify which fall-risk medications are still serving a clear purpose and which can be tapered • Consider non-pharmacological alternatives for sleep (sleep hygiene, melatonin, CBT-I), anxiety (therapy, behavioral approaches), chronic pain (PT, TENS, topical agents) • Taper benzodiazepines and Z-drugs SLOWLY (over weeks to months) — abrupt discontinuation causes withdrawal seizures + rebound anxiety • Consider Apple Watch / iPhone fall detection or a medical alert device for patients on multiple fall-risk medications • Home safety audit (grab bars, removed throw rugs, lit pathways, raised toilet seat) — the medications + the environment together drive fall risk

For families: maintaining the medication list in Kintaria, flagging fall-risk medications, and bringing it to each provider visit lets you start the deprescribing conversation specifically. "I notice mom is on lorazepam — is this still needed?" is a more actionable opening than "she's on too many medications."

When you'll hear it

When a parent is taking multiple medications. A "deprescribing review" with the PCP or pharmacist often identifies opportunities to reduce fall risk without losing therapeutic benefit.

Is this the same as…?

Terms families frequently confuse with fall-risk medication.

Is fall-risk medication the same as polypharmacy?

Polypharmacy is the BROADER phenomenon of taking many medications (5+). Fall-risk medications are a SPECIFIC subset (sedatives, anticholinergics, etc.) known to increase fall risk. A patient with polypharmacy may or may not be on fall-risk meds. Both contribute to fall risk; both deserve a deprescribing review.

Related terms

Where this comes up in caregiving

In our condition pages

See also: all glossary terms · conditions by name · step-by-step playbooks